PubRank

Hans C Korting

Author PubWeight™ 16.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2010 2.51
2 Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005 1.96
3 Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun 2002 1.82
4 The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun 2003 1.49
5 Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J Invest Dermatol 2002 1.27
6 Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 2004 1.23
7 Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun 2005 1.11
8 Targeting virulence: a new paradigm for antifungals. Drug Discov Today 2009 1.05
9 Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration. Arzneimittelforschung 2005 0.87
10 Dermatomycoses of the glabrous skin : a double-blind, randomised, comparative trial of sertaconazole 2% cream once daily versus vehicle. Clin Drug Investig 2003 0.86
11 Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. J Med Microbiol 2002 0.84
12 In vitro models for human skin disease. Drug Discov Today 2010 0.80
13 Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans. J Med Microbiol 2003 0.78
14 Host defence against Candida albicans and the role of pattern-recognition receptors. Acta Derm Venereol 2012 0.77
15 Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans. Biochem Pharmacol 2012 0.77
16 Fungi belong to the pathogens causing infectious disease. Mycoses 2005 0.75
17 ["Targets, drugs and carriers--novel therapeutic approaches"]. Pharm Unserer Zeit 2004 0.75
18 Nail penetration of sertaconazole with a sertaconazole-containing nail patch formulation. Am J Clin Dermatol 2006 0.75
19 Investigation of the synthetic route to pepstatin analogues by SPPS using O-protected and O-unprotected statine as building blocks. J Pept Sci 2009 0.75
20 [Systematic reviews]. J Dtsch Dermatol Ges 2009 0.75
21 Increasing the JIF of mycoses: a challenge with several facets. Mycoses 2007 0.75